课题基金 / 基金详情

POLY RIBOSE SYNTHETASE & ENDOTHELIAL DYSFUNCTION IN IDDM

POLY RIBOSE SYNTHETASE & ENDOTHELIAL DYSFUNCTION IN IDDM
多聚核糖合成酶
批准号:
6053423
负责人:
CSABA SZABO
金额:
$11.72万
依托单位国家:
美国
项目类别:
财政年份:
1999
资助国家:
美国
项目状态:
已结题
起止时间:
1999-09-30 至 2001-08-31

项目摘要

项目成果

CSABA SZABO的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (adapted from the applicant's abstract): In a variety of cell types (including vascular endothelial cells and vascular smooth muscle cells), exposure to cytotoxic oxidants such as peroxynitrite, results in cellular energetic failure. Upon DNA strand breakage, the nuclear enzyme poly (ADP) ribose synthetase (PARS) initiates an energy consuming, inefficient repair cycle, with transfer of the ADP ribosyl moiety of NAD to protein acceptors. The resultant depletion of dinucleotide pools is implicated in the process of cell death. In animal and cell culture models, a protective effect of PARS inhibition or lack of PARS gene has been demonstrated. Thus, the investigators propose to define the role of PARS in the process of development of endothelial injury in an in vitro model of diabetes-associated hyperglycemia. Two specific aims are proposed: (1) to establish whether inhibition or genetic inactivation of PARS affects the development of endothelial dysfunction induced by high glucose conditions; and (2) to investigate the mechanism of high glucose-induced endothelial cell death and the role of PARS in the process.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Aminooxyacetic Acid Prodrugs for Colon Cancer Therapy
  • 批准号:
    9251701
  • 项目类别:
  • 资助金额:
    $30.0万
  • 财政年份:
    2017
  • 负责人:
    CSABA SZABO
  • 依托单位:
Inhibition of Bacterial and Host-Derived H2S Production for the Therapeutic Enhancement of Anti-Bacterial Host Defense
Regulation of cellular bioenergetics by hydrogen sulfide
Poly(ADP-ribose) synthetase inhibition and diabetes
海外基金